Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Aguareles J, Paraso-Luna J, Palomares B, Bajo-Graeras R, Navarrete C, Ruiz-Calvo A, et al
Retatrutide: A Triple Hormone Agonist Retatrutide represents the next step in peptide design, acting as a triple agonist of GLP-1, GIP, and glucagon receptors
However, these versions of the drug are not considered safe or effective
The Inflation Reduction Act and Drug Price Negotiation The Inflation Reduction Act (IRA) established for the first time a mechanism for Medicare to negotiate prices directly with pharmaceutical manufacturers for certain high-spend drugs
In Lilly's latest earnings report, the company said its revenue increased nearly 30% in part because of the "volume-driven growth from Mounjaro." The drug is seen as a potential game changer in the treatment of obesity after it helped people with diabetes who were overweight or obese lose up to 15.7% of their body weight
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 22.13
US$ 20.55
US$ 27.45
